Applied Nanomedicine – Impact factor, indexing and matrices info

Applied Nanomedicine Journal . Impact Factor*

4.4

Journal Applied NanoMedicine
ISO 4Appl. NanoMed.
TypePeer Reviewed, International
Editorial BoardMultinational [Link]
DisciplineNanoMedicine, Nanobiotechnology, Biomedical Nanotechnology, Nanomedical Sciences, Drug Delivery, Nanotheranostics, Nanotherapy, Nanodiagnosis, Nanopharmaceuticals
LanguageEnglish
Article typeResearch Article, Review Article,
Short Communications, Editorial

Submit your article at Journal site:
https://pubs.thesciencein.org/journal/index.php/nanomed

#Citation Source: Google Scholar for IF (interim) Calculations. *Citation recorded as on 4-Jan-2023

Indexed In

Google ScholarLink: https://scholar.google.com/scholar?as_vis=1&q=source:Applied+source:Nanomedicine&hl=en&as_sdt=1,5

Google Scholar Citations : Applied Nanomedicine on Google Scholar
Nanomedicine Journal

Scopus indexing of the article published in the ScienceIn Journals

The Scopus indexing of the articles published in the ScienceIn Journals is a frequent query by the different publishing authors. The ScienceIn journals are peer reviewed international multidisciplinary journals meant for publication of quality research advances in different fields of science (Chemistry, Biology, Biotechnology, Pharmaceuticals Sciences, Physics, Materials Sciences, Environmental Science ) and technology fields (all engineering sub-disciplines).

The following ScienceIn journals have been evaluated by Scopus board (Scopus Content Selection & Advisory Board (CSAB)) and accepted for indexing in Scopus database. As a large number of queries arise from researchers regarding the indexing of journal contents in Scopus and other databases, this document has been made available to provide the answer to FAQ about indexing of Journal contents.

Scopus indexed ScienceIn journals are

Chemical Biology Letters
Journal of Integrated Science and Technology

FAQ and response for indexing of the articles are:

When my article published in CBL/JIST will be indexed by Scopus?

The Scopus content indexing support team continuously and periodically indexes the articles, however, we can’t provide an exact time for indexing, it may take upto 6 months or more/less depending upon when the Scopus team keeps the next round of indexing of respective journal contents.

My article published in JIST/CBL has not been indexed in Scopus while other articles from the year/volume are listed in Scopus?

You may contact the Scopus support for inclusion of your missing article/content. The details of procedure is provided on Scopus/elsevier page (click to see, use the form provided in step 2 to add your article in Scopus database).

My article is missing in Scopus listing ?

Please refer previous question.

Can I, as Author, approach the Scopus to include/index my article published in JIST / CBL as my University/Institute requires the inclusion of my article in Scopus.

You may wait for some time as Scopus team will add the contents/articles themselves, however, for urgency you may use the link/form details on Scopus site (on Scopus/elsevier page link).

————————————————

Regioselective synthesis of indole-thiazolidine-2,4-dione coupled isoxazoles as in vitro tubulin polymerization inhibitors

Regioselective synthesis of indole-thiazolidine-2,4-dione coupled isoxazoles as in vitro tubulin polymerization inhibitors

Herein we synthesized new indole-thiazolidine-2,4-dione coupled isoxazoles (7a-n) via simple reactions like N-propargylation, Knoevenagel condensation and copper (I) catalysed one pot regioselective reactions. All the newly synthesized compounds were characterized by 1H-NMR, 13C-NMR and Mass spectra and they were screened for in vitro anticancer activity against three human cancer cell lines like A549 (lung), MCF-7 (breast), and SKOV3 (ovarian) using MTT assay and etoposide was used as the standard drug. As per the results the compounds 7e, 7f and 7g where shown selectivity towards A549 cell line with IC50 values of 5.27 µM, 3.14 µM and 6.25 µM respectively and they are high active than etoposide. Further in vitro tubulin polymerization assay on three potent compounds (7e, 7f and 7g) revealed that compounds 7e and 7f have exhibited potency than standard combretastatin A-4 with IC50 values 0.82 and .044 mM respectively.

URN:NBN:sciencein.cbl.2023.v10.531

Regioselective synthesis of indole-thiazolidine-2,4-dione coupled isoxazoles as in vitro tubulin polymerization inhibitors – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/531

Chemical Biology Letters

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma

Yucca gloriosa L. has been comprehensively assessed in vitro and in vivo for its action against asthma. Y. gloriosa L. is a rich source of phenolic compounds such as gloriosaols A-E and yuccaols A-E, which exhibit potent antioxidant activity. Gloriosaols A-E and yuccaols A-E are structurally related to corticosteroids. The current study describes the in silico docking of some important anti-asthmatic phytoconstituents from the plant Y. gloriosa L. with molecular targets of asthma. Toward the recognition of the binding methods of these pharmacologically dynamic components, molecular modelling studies were carried out with target proteins, i.e., interleukin (IL)-6 (1N26), IL-13 (3LB6) and TNF-α (2AZ5), using in silico molecular docking. The components demonstrated encouraging binding interactions with the amino acid residues at the active sites of these proteins, authenticating their verified efficiency as anti-asthmatic agents. The current research, in addition, provides insight into the possible herbal drug-receptor interaction and synthetic drug montelukast sodium receptor interaction, for the possible management of asthma.

URN:NBN:sciencein.cbl.2023.v10.509

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/509

Chemical Biology Letters

Nanoemulsion of Mentha piperita essential oil active against Mycobacterium strains

Nanoemulsion of Mentha piperita essential oil active against Mycobacterium strains

Present investigation aimed to study the antimycobacterial potential of Mentha piperita essential oil fractions, identify its active constituents by GC-MS and preparation of nanoemulsion from biologically active fraction. Four oil fractions (R1, R2, R3, R4) were collected during hydrodistillation of Mentha piperiata leaves and tested in the two of mycobacterial strains by conventional disc diffusion method. Oil fractions R2 and R3 demonstrated maximum zone of inhibition of 39 mm and 36 mm in Mycobacterium smegmatis, 33 mm and 31 mm in Mycobacterium bovis BCG respectively at a dilution of 75% in DMSO compared to standard drug isoniazid (23 mm in 4 µg/ml). GC-MS analysis of the most active fraction R2 reveals the presence of menthol (70.69%), isomenthone (14.63%) and neomenthol (6.82%) as major constituents. To enhance bioavailability of oil fraction, the nanoemulsions were prepared from R2 by sonication method. Nanoemulsions, N1 and N2 prepared by varying surfactant concentrations were tested in Mycobacterium bovis BCG using quantitative and colorimetric resazurin microtiter assay (REMA). Nanoemulsions, N1 and N2 have shown 97-100 % bacterial growth inhibition at 3.125 % concentration in the culture medium compared with the culture control.

URN:NBN:sciencein.cbl.2023.v10.507

Nanoemulsion of Mentha piperita essential oil active against Mycobacterium strains – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/507

Chemical Biology Letters

Development and validation of Hand-held device for the rapid detection of Metformin in biological samples: A forensic application

Development and validation of Hand-held device for the rapid detection of Metformin in biological samples: A forensic application

Metformin is a widely used anti-diabetic drug that enhances glycaemic control by advancing the insulin sensitivity abatement of intestinal glucose absorption. Due to its versatility, it is also emerging as an abused drug leading to toxicity and fatal conditions. Detection of metformin with the existing qualitative and quantitative approaches necessitate complex and intricate instrumentation, fully facilitated laboratories, and trained scientist and technicians. Henceforth, in the current study, we have developed a hand-held electronic device-based detection system for metformin using the basic principles of spectrophotometry. It is based on the formation of a yellowish-green color complex (wavelength 680nm) which involves the oxidative coupling of 3-methyl 2-benzothiozoline hydrazone (MBTH) catalyzed by iron. The method developed has been optimized at different pH, reaction temperature, and reaction time and found to be specific, sensitive, and linear in the range of concentration 100-1000 µg/ml with the limit of detection (LOD) of 120.5 µg/ml.

URN:NBN:sciencein.cbl.2023.v10.486

Development and validation of Hand-held device for the rapid detection of Metformin in biological samples: A forensic application – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/486

Chemical Biology Letters

Current status review of HIV AIDS 2022 infection and Drug cure available

HIV infection has seen four decade and human / researchers have been struggling to find a complete cure for the HIV infection. From first identification of infection responsible for immunodeficiency related symptoms in June 1981 to increase in the spread of HIV infection throughout the world, the 2022 HIV infection marks the completion of existence of its infection of four decades in year 2022.

Though there have been continuous efforts in development of suitable cure for HIV infection and many drugs have been made available to control the infection; however, majority of drugs available have been developed towards reducing the HIV infection (preventing from reaching to stage of AIDS). All short of methods and drugs including chemical drugs, herbal formulations, biological technologies (cell based therapies and RNA/sDNA based) and nanotechnological concepts and devices have been adopted to find out the complete cure for this infection. There is need to look into the details what has been achieved so far and what is needed, particularly for the hidden reservoirs of HIV targeting.

Here is a review published in Applied NanoMedicine journal that give complete details of progress of therapeutics for HIV AIDS development. The review can be read from following link:

Nanotherapeutics and HIV: Four decades of infection canvass the quest for drug development using nanomedical technologies

https://pubs.thesciencein.org/journal/index.php/nanomed/article/view/354

(Article PDF is available for free to download and read for benefit of research community and readers).

Article is published in

Applied NanoMedicine

Readers and researchers working in nanomedicine, nanobiotechnology field are invited to publish their similar work in Applied Nanomedicine (with free open access – no fee for authors for open access for the greater benefit of community), submit your article on the journal link for consideration.


Read the above article for your similar queries: HIV review 2022; AIDS review 2022; HIV review article; HIV/AIDS; HIV infection; Cure for AIDS; Drugs for HIV; HIV life cycle; HIV symptoms; HIV review 2023; Nanodrugs for HIV; Nanomedicine of HIV; Drug delivery systems for HIV; HIV life cycle; New Drugs for HIV; FDA approved drugs for HIV; Nanobiotechnology of HIV; Latent sites of HIV infection; Liposomes mediated drug delivery for HIV hidden sites; HIV structure; HIV genome; HIV genetic material; HIV review nejm; HIV review article pdf; HIV and Covid-19; Latest nano drugs for HIV;

cancer statistics in India 2022

India’s cancer statistics are recorded by the National Cancer Registry Programme (NCRP) of the National Center for Disease Informatics and Research (NCDIR), Bengaluru, an institute of the Indian Council of Medical Research (ICMR). The ICMR-NCDIR-NCRP pulls the data through 36 PBCRs (Population-based cancer registry) and 236 HBCRs (Hospital-based cancer registry). The approximate projected cases of cancer in India were 1,392,179 (~1.4 million) in the year 2020, leading to 850,000 (~0.85 million) deaths due to cancers. The five leading cancers in India, as per reported data, were breast, lung, mouth, cervix uteri, and tongue. The sex-based incidences reported were 679,421 male patients and 712,758 female patients. Breast and cervix uteri cancers were the most common cancer types in females in India. Breast cancer incidences show steady increasing reporting trends, and the majority of incidences reported are from metropolitan cities. The increasing reports of breast cancer in women pose a concern for health agencies for necessary action to control and generate necessary medical facilities. Lung, mouth, esophagus, stomach, and nasopharynx cancer are prominent in males. Lung cancer, the leading type of cancer reported in metropolitan cities, is in general agreement with the trend line of global data. The presumptive association of lung cancer with tobacco smoking and prevalent air pollution in cities is consistent with this trend. The increasing use of synthetic pesticides in agriculture has also been considered a contributing factor along with improper industrial waste disposal practices for increasing cancer cases, particularly associated with the prevalence of new cases of cancer in specific regions. The PCBRs data indicated the association of almost a third of cancer incidences with tobacco use (smoking and chewing) in India. The social norms related to avoiding tobacco use have been emphasized towards preventive measures for most cancer cases in India.

Excerpt from the article below:

Read Full article at https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451

Global Cancer Statistics 2022: the trends projection analysis

Published in Chemical Biology Letters


Also refer above article link for queries: Cancer prevalence 2022; Cancer incidences in India; Cancer prevalence in India 2022; Cancer statistics in India; report 2023; Cancer types in India; Role of pesticides in Cancer cases in India; Tobacco smoking and cancer in India; female cancer type in India; Male cancer types in India; Total case of cancer; worldwide cancer statistics 2022; world and India cancer cases and deaths; cancer deaths in India; lung cancer cases in India; breast cancer cases in India; leading cancer types in India; covid-19 and cancer; drugs for cancer; research advances in cancer;

Global Cancer Statistics 2022: the trends projection analysis

Global Cancer Statistics 2022: the trends projection analysis

Cancer is one of the most fatal diseases of recent times that causes several deaths every year. The disease variations in different parts of the world, the impact of available medical facilities, and other socio-economic factors have impacted the proper management of this disease. The comparative statistical data of cancer types like breast, prostate, colon, lung, lymph, blood, brain, and kidney cancers can be used to design treatment strategies and therapeutics development. With the advancement of science, several drugs besides diagnostic methods have emerged to control respective cancer and have assisted in curing this disease to some extent. The comparative statistics analysis for cancer about current prevalence is included here to bring a clear framework for the efforts towards future drug development to manage this disease. The availability of new diagnostics and therapeutics and advanced medical facilities in clinics impact cancer statistics. An evaluation of current trends and statistics of cancer pathology vis-à-vis theranostics (diagnostics as well as therapeutics) progress with possible application in clinical settings constitutes the core part of the discussion in this review.

URN:NBN:sciencein.cbl.2023.v10.451

Global Cancer Statistics 2022: the trends projection analysis – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451

Chemical Biology Letters

Synthesis of new regioselective imidazole-isoxazole hybrids as in vitro antibacterial agents

Synthesis of new regioselective imidazole-isoxazole hybrids as in vitro antibacterial agents

The one-pot synthesis of some novel imidazole-isoxazole hybrids (5a-5n) and their in vitro antibacterial evaluation against Bacillus subtilis and Staphylococcus aureus was described herein. Among all, compounds 5f, 5g, 5i and 5j displayed greater zone of inhibition on Staphylococcus aureus than the standard streptomycin. Besides, compounds 5f, 5g, 5h, 5i, 5j and 5k displayed higher zone of inhibition towards Bacillus subtilis than the standard. Lastly, minimum inhibitory concentration (MIC) studies of active compounds 5f, 5g, 5h, 5i, 5j and 5k showed that the compounds 5i and 5j having lesser MIC values on Staphylococcus aureus and Bacillus subtilis than the standard.

URN:NBN:sciencein.cbl.2022.v9.425

Synthesis of new regioselective imidazole-isoxazole hybrids as in vitro antibacterial agents – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/425

Chemical Biology Letters